Jerry Treppel's Net Worth

$4.13 Million

Estimate Recalculated Nov 1, 2024 10:58AM EST

Who is Jerry Treppel

Jerry Treppel has an estimated net worth of $4.13 Million. This is based on reported shares across multiple companies, which include AKORN INC, ELITE PHARMACEUTICALS INC /DE/, and ABLE LABORATORIES INC.

SEC CIK

Jerry Treppel's CIK is 0001213711

Past Insider Trading and Trends

2004 was Jerry Treppel's most active year for acquiring shares with 7 total transactions. Jerry Treppel's most active month to acquire stocks was the month of February. 2016 was Jerry Treppel's most active year for disposing of shares, totalling 11 transactions. Jerry Treppel's most active month to dispose stocks was the month of January. 2004 saw Jerry Treppel paying a total of $367,894.75 for 50,190 shares, this is the most they've acquired in one year. In 2006 Jerry Treppel cashed out on 792,957 shares for a total of $1,643,040.00, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AKORN INC

Investor

Updated Aug 11, 2009


Form 4	5.21%	20.00K	—	—	Aug 11, 2009	404.02K	Grant	—	Aug 07
Form 4	—	—	$2.00	$20.00K	Dec 22, 2008	384.02K	Options	—	Dec 18
Form 4	-3.48%	-13.50K	$1.18	-$15.93K	Dec 08, 2008	374.02K	Sale	—	Dec 05
Form 4	-2.52%	-10.00K	$1.54	-$15.37K	Dec 02, 2008	387.52K	Sale	—	Nov 28 - Dec 02
Form 4	-6.06%	-25.00K	$4.45	-$111.25K	May 29, 2008	387.52K	Sale	—	May 28
Form 4	-0.43%	-1.79K	—	—	Feb 29, 2008	412.52K	Grant	—	Feb 27
Form 4	2.41%	10.00K	—	—	Jan 03, 2008	424.31K	Grant	—	Jan 01
Form 4	-1.77%	-15.00K	$7.54	-$112.40K	Dec 04, 2007	833.62K	Sale	—	Nov 29 - Nov 30
Form 4/A	-2.28%	-10.00K	$7.49	-$74.90K	Oct 22, 2007	429.31K	Sale	—	Sep 12
Form 4	-2.13%	-10.00K	$7.49	-$74.90K	Sep 14, 2007	459.31K	Sale	—	Sep 12
Form 4	-0.42%	-2.00K	$6.25	-$12.50K	Jan 26, 2007	469.31K	Grant	—	Dec 29
Form 4	—	50.00K	—	—	Jan 04, 2007	50.00K	Grant	—	Jan 01
Form 4	-40.90%	-326.11K	$5.00	-$1.63M	Nov 20, 2006	471.31K	Sale	—	Nov 16
Form 4	-2.98%	-23.54K	$1.00	$83.33K	Sep 13, 2006	767.42K	Options	—	Sep 11
Form 4	-0.55%	-10.90K	$4.25	-$46.22K	Jun 20, 2006	1.98M	Sale	—	Jun 16
Form 4	-1.29%	-13.60K	$4.22	-$57.31K	Jun 19, 2006	1.04M	Sale	—	Jun 15
Form 4/A	-0.92%	-5.00K	$4.24	-$21.15K	Jun 13, 2006	539.45K	Sale	—	Jun 09
Form 4	-1.83%	-9.90K	$4.24	-$41.98K	Jun 13, 2006	529.65K	Sale	—	Jun 09
Form 4	-1.13%	-9.40K	$4.32	-$40.60K	Jun 12, 2006	824.82K	Sale	—	Jun 08
Form 4	-1.21%	-10.50K	$4.31	-$45.24K	Jun 09, 2006	856.52K	Sale	—	Jun 07
Form 4	-1.03%	-25.40K	$4.26	-$108.00K	Jun 08, 2006	2.43M	Sale	—	Jun 06
Form 4	-1.27%	-39.40K	$4.25	-$166.73K	Jun 07, 2006	3.06M	Sale	—	Jun 05
Form 4	—	10.00K	—	—	Jun 01, 2006	10.00K	Grant	—	May 23
Form 4	110.06%	22.01K	—	—	Feb 13, 2006	758.49K	Options	—	Mar 31 - Jan 13
Form 4	130.50%	10.00K	$2.61	$26.10K	Apr 04, 2005	17.66K	Grant	—	Apr 01
Form 4/A	2.33%	113.00	—	—	Aug 16, 2004	4.97K	Acquisition	—	Dec 31 - Jun 30
Form 4	1.16%	10.11K	$1.38	$20.08K	Jul 13, 2004	883.56K	Acquisition	—	Jun 30 - Jul 08
Form 3	—	—	—	—	Nov 18, 2003	—	—	—	—

Showing 28 results

ELITE PHARMACEUTICALS INC /DE/

Chairman Board

Updated Mar 21, 2016

View Quote Details


Form 4	-6.95%	-570.52K	$0.34	-$196.06K	Mar 21, 2016	7.64M	Sale	—	Mar 17 - Mar 18
Form 4	-2.38%	-200.46K	$0.32	-$63.23K	Feb 24, 2016	8.21M	Sale	—	Feb 22 - Feb 24
Form 4	-8.54%	-785.23K	$0.29	-$270.37K	Feb 18, 2016	8.41M	Sale	—	Jan 29 - Feb 17
Form 4	-1.68%	-157.50K	$0.30	-$47.58K	Nov 18, 2015	9.20M	Sale	—	Nov 13 - Nov 18
Form 4	0.95%	87.71K	$0.34	$30.00K	Mar 09, 2015	9.35M	Grant	—	Mar 05
Form 4	188.99%	6.06M	$23,573.79	-$100.00K	Sep 12, 2014	9.27M	Options	—	Sep 10
Form 4/A	—	—	$0.13	—	Jun 23, 2014	3.21M	Options	—	Jun 17
Form 4	—	—	$0.25	—	Jun 18, 2014	3.21M	Options	—	Jun 17
Form 4	—	—	$0.06	$10.80K	Mar 18, 2014	2.83M	Options	—	Mar 12
Form 3/A	—	—	—	—	Mar 18, 2014	190.00K	—	—	—
Form 4	13.59%	330.16K	$0.09	$30.01K	Mar 03, 2014	2.76M	Grant	—	Feb 25
Form 4	-100.00%	-600.00K	$16,671.82	—	Feb 11, 2014	4.24	Options	—	Feb 07
Form 4	14.94%	277.06K	$0.08	$22.16K	Mar 11, 2013	2.13M	Grant	—	Mar 07
Form 4	-100.00%	-3.20K	$0.14	-$454.40	Apr 23, 2012	1.85M	Sale	—	Apr 19
Form 4	23.06%	347.45K	$0.10	$33.67K	Mar 21, 2012	1.85M	Grant	—	Mar 20
Form 4	53.24%	587.83K	$0.04	$23.51K	Mar 16, 2011	1.69M	Purchase	—	Feb 03
Form 4	23.15%	500.00K	$0.07	$34.60K	Jul 16, 2010	2.66M	Purchase	—	Jul 16
Form 4	80.96%	749.92K	$500.10	—	Jul 01, 2009	1.68M	Options	—	Jun 03
Form 3/A	—	—	—	—	Jul 01, 2009	—	—	—	—
Form 3	—	—	—	—	Nov 06, 2008	180.00K	—	—	—

Showing 20 results

ABLE LABORATORIES INC

Investor

Updated Mar 04, 2005


Form 4	—	20.00K	—	—	Mar 04, 2005	20.00K	Grant	—	Mar 02
Form 4	—	7.00K	$17.15	$120.05K	Feb 26, 2004	7.00K	Grant	—	Feb 24
Form 4	—	13.00K	$17.52	$227.76K	Feb 04, 2004	13.00K	Grant	—	Jan 30
Form 4	-0.07%	-112.00	$23.45	-$2.63K	Aug 06, 2003	161.32K	Sale	—	Aug 04

Showing 4 results